Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Neural Regulation01:37

Neural Regulation

39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

452
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
452
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

198
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
198

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>GCH1</i> p.Ser80Asn Confers Risk for Parkinson's Disease in East Asian Populations.

medRxiv : the preprint server for health sciences·2026
Same author

Longitudinal Repeatome Remodeling in Peripheral Blood Following Parkinson's Disease Diagnosis.

Genes·2026
Same author

Distinct transcriptomic effects of intermittent and chronic caloric restriction in mammary fat pad of a breast cancer mouse model.

PloS one·2025
Same author

Functional Attributes of Synovial Fluid from Osteoarthritic Knee Exacerbate Cellular Inflammation and Metabolic Stress, and Fosters Monocyte to Macrophage Differentiation.

Biomedicines·2025
Same author

The Exon-Based Transcriptomic Analysis of Parkinson's Disease.

Biomolecules·2025
Same author

AskBeacon-performing genomic data exchange and analytics with natural language.

Bioinformatics (Oxford, England)·2025

Related Experiment Video

Updated: May 31, 2025

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.1K

Exploring the Potential Imaging Biomarkers for Parkinson's Disease Using Machine Learning Approach.

Illia Mushta1, Sulev Koks2, Anton Popov3,4

  • 1Department of Electronic Computational Equipment Design, National Technical University of Ukraine "Igor Sikorsky Kyiv Polytechnic Institute", 03056 Kyiv, Ukraine.

Bioengineering (Basel, Switzerland)
|January 24, 2025
PubMed
Summary

Machine learning accurately diagnosed Parkinson's disease (PD) using Dopamine transporter scans (DATSCAN). The contralateral putamen SBR biomarker proved most effective, simplifying diagnosis and improving patient outcomes.

Keywords:
AdaBoostDATSCANParkinson’s diseasebasal gangliaclassificationmachine learning

More Related Videos

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.6K
Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

945

Related Experiment Videos

Last Updated: May 31, 2025

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.1K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.6K
Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

945

Area of Science:

  • Neuroscience and Medical Imaging
  • Artificial Intelligence in Healthcare

Background:

  • Parkinson's disease (PD) involves dopamine neuron loss, impacting motor and neuropsychiatric functions.
  • Dopamine transporter scans (DATSCAN) using SPECT assess dopaminergic neuron integrity.

Purpose of the Study:

  • To develop a machine learning (ML) algorithm for PD diagnosis using DATSCAN data.
  • To identify a key biomarker from DATSCAN images for improved diagnostic accuracy.

Main Methods:

  • Trained an AdaBoost classifier on 13 DATSCAN parameters and handedness from 1309 individuals (PPMI database).
  • Utilized Local Interpretable Model-Agnostic Explainer (LIME) for biomarker identification and model interpretability.

Main Results:

  • Achieved 98.88% accuracy and 99.81% AUC with the ML model.
  • Identified contralateral putamen SBR as the most significant predictive feature for PD diagnosis.

Conclusions:

  • The ML approach simplifies PD diagnosis by focusing on a single, interpretable biomarker.
  • This enhances diagnostic precision and supports clinical decision-making, despite DATSCAN's limitations in early-stage detection.